Aratana Therapeutics Inc (fka PETX)

[terry hallinan]

Stifel Calls Aratana Therapeutics a 'Buy' on Entyce, Galliprant Optimism

https://tinyurl.com/y8dbyoux

Veterinarians and other creepies shorting PETX might could get some real hurt despite the hefty down draft today.

I thought Entyce was badly overlooked but Galliprant gets a gold star from us and wonderment that Eli Lilly is not apparently developing the human EP4 antagonist.

It was a surprise to me when PETX bragged they owned all the rights to the drug's mechanism of action against osteoarthritis. Our border collie/lab mix that was all but on her deathbed is bouncing around in the snow like a pup while my is very badly crippled.

Our mail order supplier rates even a generic higher - which seems insane.

Quite possible the piprant that was modified to keep the joints lubricated with no apparent effect on the arthritis proper will harm humans but I can find no evidence anyone is looking.

PETX's new Japanese partner also has an EP4 antagonist. No difference was specified though it was included in licensing.

Best, Terry